Square Pharmaceuticals PLC. (DSE:SQURPHARMA)
Bangladesh · Delayed Price · Currency is BDT 219.60
0.00 (0.00%)
At close: Oct 19, 2026
DSE:SQURPHARMA Financials Overview
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 83,527 | 76,288 | 70,101 | 60,708 | 57,598 | 50,703 |
Revenue Growth | 10.11% | 8.83% | 15.47% | 5.40% | 13.60% | 10.52% |
Gross Profit Gross Profit Growth | 40,290 | 35,911 | 32,553 | 28,235 | 28,879 | 25,233 |
Operating Income Operating Income Growth | 21,817 | 19,393 | 17,974 | 16,690 | 16,860 | 15,269 |
Net Income Net Income Growth | 25,863 | 23,968 | 20,926 | 18,980 | 18,157 | 15,947 |
Earnings Per Share EPS Growth | 29.18 | 27.04 | 23.61 | 21.41 | 20.48 | 17.99 |
EPS Growth | 10.04% | 14.54% | 10.25% | 4.53% | 13.86% | 19.42% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Bangladesh Bangladesh Growth | 98,243 | 88,900 | 81,570 | 70,334 | 64,707 | 56,839 |
Export Export Growth | 2,340 | 2,550 | 2,403 | 1,956 | 1,700 | 1,508 |
Unallocated Unallocated Growth | -17,056 | -15,162 | -13,871 | -11,583 | - | - |
Total Total Growth | 83,527 | 76,288 | 70,101 | 60,708 | 66,407 | 58,346 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 72,574 | 65,442 | 61,306 | 54,684 | 53,309 | 47,988 |
Total Debt Total Debt Growth | 356.03 | 825.5 | 1,429 | 1,987 | 1,914 | 103.71 |
Net Cash (Debt) Net Cash Growth | 72,218 | 64,616 | 59,877 | 52,697 | 51,395 | 47,885 |
Net Cash Growth | 22.26% | 7.92% | 13.62% | 2.53% | 7.33% | 35.82% |
Net Cash Per Share Net Cash Per Share Growth | 81.47 | 72.89 | 67.55 | 59.45 | 57.98 | 54.02 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 22,300 | 17,302 | 18,529 | 8,546 | 12,875 | 10,976 |
Capital Expenditures CapEx Growth | -8,321 | -6,177 | -4,181 | -2,861 | -6,183 | -3,798 |
Free Cash Flow Free Cash Flow Growth | 13,979 | 11,125 | 14,348 | 5,685 | 6,692 | 7,178 |
Free Cash Flow Growth | 70.62% | -22.46% | 152.37% | -15.04% | -6.78% | -17.66% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 48.24% | 47.07% | 46.44% | 46.51% | 50.14% | 49.77% |
Operating Margin | 26.12% | 25.42% | 25.64% | 27.49% | 29.27% | 30.11% |
Pretax Margin | 37.73% | 37.87% | 36.11% | 38.91% | 39.52% | 39.37% |
Profit Margin | 30.96% | 31.42% | 29.85% | 31.26% | 31.52% | 31.45% |
FCF Margin | 16.73% | 14.58% | 20.47% | 9.37% | 11.62% | 14.16% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 23, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Dividend Per Share Dividend Per Share Growth | 12.000 | 12.000 | 11.000 | 10.500 | 10.000 | 6.000 |
Dividend Per Share Growth | 9.09% | 9.09% | 4.76% | 5.00% | 66.67% | 34.04% |
Dividend Yield | 5.46% | 5.74% | 5.22% | 5.00% | 4.61% | 2.78% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 23, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 7.53 | 7.73 | 8.93 | 9.80 | 10.58 | 11.98 |
Forward PE | 6.80 | 7.25 | 8.30 | 9.10 | 9.93 | 10.40 |
P/FCF Ratio | 13.93 | 16.65 | 13.03 | 32.71 | 28.71 | 26.61 |
PS Ratio | 2.33 | 2.43 | 2.67 | 3.06 | 3.34 | 3.77 |